5-amino-1mq nnmt inhibition — 50mg | Inhibitor (NAD+ Axis) 5-Amino-1MQ Research Compound 10mg |
Description
Published preclinical work has described: Reduced de novo lipogenesis in adipocytes Reduced hepatic lipogenesis in diet-induced obesity models Improved adipose tissue metabolic markers Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice

Ethics declarations Competing interests John Varga- Receives consulting fees from, and owns equity shares in TeneoFour

Call us at (480) 808-8499 for current pricing

If you have malabsorption syndrome (such as short bowel syndrome, certain bariatric surgery patients, chronic pancreatitis, or celiac disease that severely impairs nutrient uptake), you might need these injections indefinitely to prevent recurrent deficiencies

BMJ 2003;327:55760
